Single pemetrexed is noninferior to platinum-based pemetrexed doublet as first-line treatment on elderly Chinese patients with advanced nonsquamous nonsmall cell lung cancer

BACKGROUND: To evaluate the clinical efficacy and toxicity of single pemetrexed treatment compared with platinum-based pemetrexed doublet pemetrexed-based as first-line treatment for advanced nonsquamous nonsmall cell lung cancer (NS-NSCLC) in elderly Chinese patients. METHODS: The study retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Xiaolin, Li, Wei, Lu, Binbin, Wang, Zhaoxia, Yang, Min, Fan, Weifei, Meng, Lijuan, Lv, Zhigang, Xie, Yuchun, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369876/
https://www.ncbi.nlm.nih.gov/pubmed/28296721
http://dx.doi.org/10.1097/MD.0000000000006002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369876/
https://www.ncbi.nlm.nih.gov/pubmed/28296721
http://dx.doi.org/10.1097/MD.0000000000006002

Ejemplares similares